SARAH DIPADOVA: Open Payments
NPI 1477818581 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$98 in 4 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $58 · 2025 $98
Food & beverage: $98
| Company | Payments | Amount |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $19 |
Products named: ENVARSUS, LOKELMA, Veltassa.
Industry payments across PA — which companies pay providers there.
